Optometrists in Brookfield, CT Accepting Medicare
6 Optometrists found. Showing 1 - 6
 Dr. Jeffrey Seth Migdol, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 246 Federal Rd, C 12, Brookfield, CT 06804 Phone: 203-775-1209 Fax: 203-740-8151 |
Dr. John J Durffy, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 200 Federal Rd, Brookfield, CT 06804 Phone: 203-775-4337 |
 Dr. Pamela Suzanne Schramm, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 246 Federal Rd., Suite C-12, Brookfield, CT 06883 Phone: 203-775-1209 Fax: 203-740-8151 |
 Brookfield Vision Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 246 Federal Rd, Suite C-12, Brookfield, CT 06804 Phone: 203-775-1209 Fax: 203-740-8151 |
Dr. Edlira Alushi X, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 49 Federal Rd, Brookfield, CT 06804 Phone: 203-740-2040 Fax: 203-740-2040 |
Dr. Evan Tirado, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 246 Federal Rd Unit A-11, Brookfield, CT 06804 Phone: 203-775-1209 |
News Archive
South Asian nations explore ways to strengthen collaboration at forum for health research
Delegates and officials from Bangladesh, Bhutan, Nepal, Pakistan, Sri Lanka, Maldives, and Thailand representing their health and medical research councils on Tuesday in New Delhi concluded a three-day South Asian Forum for Health Research (SAHFer) hosted by the Indian Council of Medical Research (ICMR), Pharmabiz.com reports.
New study could lead to better and more targeted drugs for arthritis and cancer
The increased risk of heart attack or stroke associated with many arthritis drugs may be avoidable, according to a new international study co-authored by researchers at Imperial College London.
TCD announces first patient treated in its TCD-717 Phase I trial
Traslational Cancer Drugs Pharma, S.L. ("TCD") announced today that the first patient was treated on Friday the 18th of February with TCD-717 in a Phase I study performed in patients with advanced solid tumors. TCD-717 is a first-in-class, small molecule that precisely inhibits Choline Kinase Alpha, an enzyme heavily involved in the carcinogenic process. A total of 30 patients are planned to be treated in the trial, which will be conducted in accordance with FDA approval, in two leading medical centers in the U.S. The
FDA approves treatment for diarrhea caused by Cryptosporidium infection
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
› Verified 9 days ago
Chiropractors
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Podiatrists